Mr. Greg Holman is the Chief Commercial Officer of the Company. His responsibilities include leading the company’s global commercial strategy and execution across international markets, playing a central role in advancing the company's One MicroPort strategy.
Before joining MicroPort, Mr. Holman held senior leadership roles at Boston Scientific and Stryker across multiple therapeutic areas, and most recently served as Operating Partner at LYFE Capital. He brings over 25 years of MedTech leadership experience across the United States and Asia Pacific, including more than a decade based in China.
Mr. Holman holds an MBA from Olin Business School at Washington University in St. Louis, where he graduated as Valedictorian. He also holds a bachelor’s degree in Business Management and Political Science from Wittenberg University.